Depression enhanced the production of autoantibodies against 16α‑hydroxyestrone-estrogen receptor adduct in breast cancer
Authors:
- 27 November 2018
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 66, 251-259
Abstract
No abstract availableKeywords
Funding Information
- King Khalid University (R.G.P.1/53/39)
This publication has 53 references indexed in Scilit:
- Autoantibodies against Muscarinic Receptors in Breast Cancer: Their Role in Tumor AngiogenesisPLOS ONE, 2013
- CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of MacrophagesCancer Cell, 2009
- The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancerInternational Journal Of Clinical Practice, 2007
- Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progressionBreast Cancer Research, 2007
- A meta-analysis on depression and subsequent cancer riskClinical Practice & Epidemiology in Mental Health, 2007
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological studyBritish Journal of Cancer, 1999
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- Mastectomy or conservation for early breast cancer: Psychological morbidityEuropean Journal of Cancer, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976